Artefact Report – Revolutionizing Drug Development:
Unleashing the Power of AI in Clinical Trials
AI is transforming clinical trials by enabling faster, data-driven processes and significantly reducing costs and timelines. Generative AI optimizes trial design, patient recruitment, and data analysis, with decentralized trials and predictive modeling delivering key innovations.
This comprehensive guide dives deep into how AI is transforming the clinical trial landscape—making trials faster, more efficient, and more inclusive. With insights from industry leaders from pharmaceuticals such as Johnson & Johnson, Pfizer, and Servier, and tech partners and startups like Deemea, Elaia, Google, Inato, Klineo, and Naaia. This paper is a must-read for pharma innovators and healthcare professionals, and more.
Download the report
What’s inside? It is composed of 4 main chapters
[Foreword] AI in Clinical Trials – An ongoing revolution.
Real-world impact – Get a closer look at transformative AI use cases across the clinical trial value chain
Fueling Innovation: Exploring the expanding ecosystem of AI-driven trials.
Challenges Ahead: Overcoming barriers to fully realize AI’s potential.
Watch the conference with Luca Mollo, Vice President, Medical Director France, M.D. at Pfizer and our Artefact experts, Thomas Filaire, Partner, and Léa Giroulet, Senior Data Consultant, about the main insights from this report:
AI for Health Summit – 7th edition with the entire Health & Pharmaceuticals ecosystem
Last week Artefact organized the international Summit AI for Health where we welcomed 2000+ participants, that brought together:
130+ high-level speakers from the major actors of the Pharma and Health sector made us the honour of sharing their return of experience: Pfizer, Servier, Biogen, Roche, Novo Nordisk, Takeda, AMGEN, Clariane, French Ministry of Digital Health, Healthcare Data Institute, EIT Health, PariSanté Campus, Resah, Unicancer.
Our Technology Partners: Amazon Web Services, InstaDeep, IQVIA France, Microsoft, MyData-TRUST, Nebius, Pure Storage, Salesforce, Sqilline Health, Theodo HealthTech, TriNetX, VIDAL.
Discover the complete program of our summit here.
Some of the AI for Health conference replays
“Leaders’ POV: Accelerating drug innovation through AI.”
– Virginie Dominguez, Executive Vice-President Digital, Data & IT at Servier,
– Dr. Claude Bertrand, Executive Vice-President R&D at Servier,
– Paul de Balincourt, Partner – Healthcare Data & AI Transformation at Artefact
“AI: On a mission to make drug development faster and smarter.”
– Reda Guiha, Country President France at Pfizer,
– Damien Gromier CEO & Founder of AI for Health
“Strategic vision for rare diseases.”
– Prof. Anita Burgun, Associate Researcher at Institute Imagine,
– Thibaud Guymard, Head of Innovation, Services & Digital at Biogen,
– Solange Roumengous, Head of Industrial Partnerships at the French National Database of Rare Diseases,
– Corinne Blachier Poisson, President France at AMGEN,
– François Macary, Semantic interoperability expert at Use & Share,
– Virginie Lasserre, External Affairs Director at Johnson & Johnson
“Omni-channel engagement of HCPs in the Age of GenAI.”
– Patrice Haton, Strategic Solution Engineer, Leader HLS France at Salesforce,
– Gaëlle Boterf, Director, Industry Advisor – Healthcare & Life Sciences EMEA at Salesforce,
– Dr. Grégoire Pigné, CEO & Co-founder of PulseLife,
– Florent Hassen, Global Product Owner – Customer Engagement Suite at Roche,
– Marine Sortais, Consulting Director at Artefact
“The Generative AI revolution for drug discovery.”
– Yann Gaston-Mathé, CEO & Founder at Iktos,
– Alex Merwin Head of Growth, Healthcare & Life Sciences Startups at AWS,
– Samantha Jerusalmy, Partner at Elaia,
– Hervé Minoux, Head of AI for Large Molecule Research at Sanofi,
– Sandrine Cochard, Editorial Director at Mind Group
“Preventing frailty and AI-geing well.”
– Anne-Charlotte Dymny, Chief Information & Digital Officer at Clariane,
– Adeline Martin, Project Coordinator at CNES MEDES,
– Thomas Filaire, Partner at Artefact
ACCESS ALL REPLAYS
aiforhealth.artefact.com
The Adopt AI Summit 2025 on September 17th and 18th at Grand Palais, Paris. Save the dates!
Following the success of its inaugural edition on June 5th at Station F, the Adopt AI International Summit is back! Mark your calendars for September 16th (VIP dinner) and September 17th-18th (full days) at the iconic Grand Palais, a symbol of Parisian elegance and history, famously featured in the Paris 2024 Olympics.
This one-of-a-kind event brings together all major Artefact initiatives AI for Finance, AI for Health, AI for Industry, AI for Sport, AI for Luxury, AI for Tourism, AI for Life, AI for the Planet, offering an unparalleled opportunity to hear from the world’s top thought leaders in AI transformation and business innovation).
All our tech partners, startups, and scaleups will also be present to showcase their latest products and solutions.
Contact Damien Gromier, CEO and founder of the Adopt AI Summit by Artefact, to explore sponsorship and exhibition opportunities.
DATA ACCELERATION PROGRAMS | AI SOLUTIONS | DATA MARKETING
